229 related articles for article (PubMed ID: 31286349)
1. Dose Reduction in Brain [
Soret M; Piekarski E; Yeni N; Giron A; Maisonobe JA; Khalifé M; Zaslavsky C; Bertaux M; Habert MO; Kas A
Mol Imaging Biol; 2020 Jun; 22(3):695-702. PubMed ID: 31286349
[TBL] [Abstract][Full Text] [Related]
2. Limits for Reduction of Acquisition Time and Administered Activity in
Schiller F; Frings L; Thurow J; Meyer PT; Mix M
J Nucl Med; 2019 Dec; 60(12):1764-1770. PubMed ID: 31028167
[TBL] [Abstract][Full Text] [Related]
3. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.
Soret M; Maisonobe JA; Desarnaud S; Bergeret S; Causse-Lemercier V; Berenbaum A; Rozenblum L; Habert MO; Kas A
Sci Rep; 2022 Sep; 12(1):15341. PubMed ID: 36097015
[TBL] [Abstract][Full Text] [Related]
5. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
Fällmar D; Haller S; Lilja J; Danfors T; Kilander L; Tolboom N; Egger K; Kellner E; Croon PM; Verfaillie SCJ; van Berckel BNM; Ossenkoppele R; Barkhof F; Larsson EM
Eur Radiol; 2017 Oct; 27(10):4237-4246. PubMed ID: 28374078
[TBL] [Abstract][Full Text] [Related]
6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
[TBL] [Abstract][Full Text] [Related]
9. Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode data.
Gatidis S; Würslin C; Seith F; Schäfer JF; la Fougère C; Nikolaou K; Schwenzer NF; Schmidt H
Hell J Nucl Med; 2016; 19(1):15-8. PubMed ID: 26929936
[TBL] [Abstract][Full Text] [Related]
10. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
[TBL] [Abstract][Full Text] [Related]
11. Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.
Anazodo UC; Finger E; Kwan BYM; Pavlosky W; Warrington JC; Günther M; Prato FS; Thiessen JD; St Lawrence KS
Neuroimage Clin; 2018; 17():405-414. PubMed ID: 29159053
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of
Sah BR; Ghafoor S; Burger IA; Ter Voert EEGW; Sekine T; Delso G; Huellner M; Dedes KJ; Boss A; Veit-Haibach P
J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
[TBL] [Abstract][Full Text] [Related]
13. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
14. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
Rostomian AH; Madison C; Rabinovici GD; Jagust WJ
J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
[TBL] [Abstract][Full Text] [Related]
16. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Jena A; Taneja S; Goel R; Renjen P; Negi P
Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
[TBL] [Abstract][Full Text] [Related]
18. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
19. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
Shepherd TM; Nayak GK
Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
[TBL] [Abstract][Full Text] [Related]
20. Simulation of Tracer Dose Reduction in
Seith F; Schmidt H; Kunz J; Küstner T; Gatidis S; Nikolaou K; la Fougère C; Schwenzer N
J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
